550 related articles for article (PubMed ID: 11949985)
1. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
[TBL] [Abstract][Full Text] [Related]
3. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
4. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
[TBL] [Abstract][Full Text] [Related]
5. Frequent needle exchange use and HIV incidence in Vancouver, Canada.
Wood E; Lloyd-Smith E; Li K; Strathdee SA; Small W; Tyndall MW; Montaner JS; Kerr T
Am J Med; 2007 Feb; 120(2):172-9. PubMed ID: 17275459
[TBL] [Abstract][Full Text] [Related]
6. Condom use among injection drug users accessing a supervised injecting facility.
Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
Nelson KE; Vlahov D; Solomon L; Cohn S; Muñoz A
Arch Intern Med; 1995 Jun; 155(12):1305-11. PubMed ID: 7778962
[TBL] [Abstract][Full Text] [Related]
8. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
9. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV infection in provincial prisons in British Columbia.
Rothon DA; Mathias RG; Schechter MT
CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754
[TBL] [Abstract][Full Text] [Related]
11. Rate of methadone use among Aboriginal opioid injection drug users.
Wood E; Montaner JS; Li K; Barney L; Tyndall MW; Kerr T
CMAJ; 2007 Jul; 177(1):37-40. PubMed ID: 17606937
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.
Roy E; Richer I; Morissette C; Leclerc P; Parent R; Claessens C; Blanchette C; Alary M
AIDS; 2011 Sep; 25(15):1897-903. PubMed ID: 21785319
[TBL] [Abstract][Full Text] [Related]
13. High pregnancy rates and reproductive health indicators among female injection-drug users in Vancouver, Canada.
Weber AE; Tyndall MW; Spittal PM; Li K; Coulter S; O'Shaughnessy MV; Schechter MT
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):52-8. PubMed ID: 12725675
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with geographic migration among a cohort of injection drug users.
Rachlis BS; Hogg RS; Wood E; Li K; Kerr T
Health Place; 2008 Sep; 14(3):536-43. PubMed ID: 18410717
[TBL] [Abstract][Full Text] [Related]
15. Young and recent-onset injecting drug users are at higher risk for HIV.
Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
[TBL] [Abstract][Full Text] [Related]
16. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
17. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M
AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942
[TBL] [Abstract][Full Text] [Related]
18. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users.
Corneil TA; Kuyper LM; Shoveller J; Hogg RS; Li K; Spittal PM; Schechter MT; Wood E
Health Place; 2006 Mar; 12(1):79-85. PubMed ID: 16243682
[TBL] [Abstract][Full Text] [Related]
19. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and risk behaviours among young gay and bisexual men in Vancouver.
Strathdee SA; Martindale SL; Cornelisse PG; Miller ML; Craib KJ; Schechter MT; O'Shaughnessy MV; Hogg RS
CMAJ; 2000 Jan; 162(1):21-5. PubMed ID: 11216194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
